Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Synovial 1Sarcoma 1Rhabdomyosarcoma 1Neurofibrosarcoma 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Fibrosarcoma 1

Interventions

Doxorubicin 8Ifosfamide 6Radiotherapy 4Dacarbazine 3Trabectedin 2Filgrastim 2pegfilgrastim 1olaratumab 1indolepropanol phosphate 1anlotinib 1Watchful Waiting 1Tablets 1Surgical Procedures, Operative 1Rosuvastatin Calcium 1Radiotherapy, Conformal 1PM 01183 1Observation 1Neoadjuvant Therapy 1Midazolam 1Etoposide 1Digoxin 1Diathermy 1Combined Modality Therapy 1Chemotherapy, Adjuvant 1ADI PEG20 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leiomyosarcoma × Combined Modality Therapy × Clear all
NCT00061984 2014-10-27

Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
455 enrolled
Sarcoma

Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡